Scarica l'app Stockscreener
0.334
3.94%
-0.0137
Dopo l'orario di chiusura:
.33
-0.004
-1.20%
Precedente Chiudi:
$0.3477
Aprire:
$0.3554
Volume 24 ore:
1.19M
Relative Volume:
1.71
Capitalizzazione di mercato:
$31.02M
Reddito:
$1.22M
Utile/perdita netta:
$-14.15M
Rapporto P/E:
-1.2846
EPS:
-0.26
Flusso di cassa netto:
$-6.55M
1 W Prestazione:
+14.86%
1M Prestazione:
-6.70%
6M Prestazione:
+11.33%
1 anno Prestazione:
-19.30%
Intervallo 1D:
$0.323
$0.36
Intervallo di 1 settimana:
$0.285
$0.36
Portata 52W:
$0.2525
$0.4985
IGC Pharma Inc Stock (IGC) Company Profile
Nome
IGC Pharma Inc
Settore
Industria
Telefono
301-983-0998
Indirizzo
4336 Montgomery Avenue, Bethesda, MD
Confronta IGC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IGC
IGC Pharma Inc
|
0.334 | 32.29M | 1.22M | -14.15M | -6.55M | -0.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
IGC Pharma Inc Borsa (IGC) Ultime notizie
IGC Pharma Increases Authorized Shares to 600 Million - TipRanks
IGC Pharma (IGC) Advances in FDA-regulated Cannabinoid Drug Deve - GuruFocus
IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cann - pharmiweb.com
IGC Pharma Positions as a Singular Beneficiary of Emerging Federal Momentum Toward Schedule III Cannabinoid Medicines - The Joplin Globe
IGC Pharma (IGC) spotlights Alzheimer's cannabinoid trial amid Schedule III talks - Stock Titan
It is Poised to be a Bull Market for IGC Pharma Inc (IGC) - setenews.com
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75." - Digital Journal
IGC Pharma : Announces Coverage Report by Ascendiant Capital Markets about the “Reports Q2 results. We believe more positive clinical data and progress in 2025/26 to be strong catalysts for stock. Raising P/T to $4.75.” - marketscreener.com
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q2 results. We - pharmiweb.com
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the - Big News Network.com
IGC Pharma Achieves 65% Enrollment In Phase 2 CALMA Trial For Alzheimer's Agitation - Nasdaq
Ascendiant Capital Markets Issues Positive Forecast for IGC Pharma (NYSEMKT:IGC) Stock Price - Defense World
Ascendiant Capital Maintains IGC Pharma (IGC) Buy Recommendation - Nasdaq
IGC Pharma (IGC): Ascendiant Capital Raises Price Target to $4.7 - GuruFocus
IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 C - GuruFocus
IGC Achieves Significant Enrollment Progress in Phase 2 Alzheimer's Trial - GuruFocus
IGC Pharma Reports 65% Patient Enrollment Milestone in Phase 2 CALMA Alzheimer's Agitation Trial - pharmiweb.com
Can IGC Pharma Inc. stock test all time highsEarnings Recap Report & Fast Gaining Stock Reports - Newser
Why IGC Pharma Inc. (IGS1) stock is favored by hedge fundsQuarterly Performance Summary & Fast Moving Trade Plans - Newser
Why institutional investors increase stakes in IGC Pharma Inc. (IGS1) stockInflation Watch & Fast Entry Momentum Alerts - Newser
Why IGC Pharma Inc. (IGS1) stock attracts HNW investorsBuy Signal & Weekly Breakout Watchlists - Newser
Is IGC Pharma Inc. (IGS1) stock worth holding before Fed meeting2025 Price Action Summary & Low Risk Entry Point Tips - Newser
IGC Pharma (NYSE American: IGC) registers 978,235 shares for stockholder resale - Stock Titan
Is IGC Pharma Inc. (IGS1) stock a top pick for value investorsJuly 2025 Review & Weekly Watchlist for Consistent Profits - Newser
Is IGC Pharma Inc. stock worth holding before Fed meetingWeekly Trend Recap & Capital Efficiency Focused Ideas - Newser
Will IGC Pharma Inc. stock beat value stocksGDP Growth & Safe Capital Growth Plans - Newser
IGC Pharma Publishes Caregiver's Guide on Alzheimer's Disease - GuruFocus
IGC Pharma Announces Publication of Landmark Caregiver Book on Alzheimer's Disease - Big News Network.com
Why IGC Pharma Inc. stock stays undervaluedMarket Volume Summary & Expert Curated Trade Setups - Newser
Will IGC Pharma Inc. (IGS1) stock beat growth indexesShare Buyback & Verified Trade Idea Suggestions - Newser
IGC Pharma (NYSE American: IGC) backs expert-led Alzheimer's caregiver guide - Stock Titan
How IGC Pharma Inc. stock reacts to weak economyWeekly Risk Summary & Reliable Volume Spike Trade Alerts - Newser
What drives IGC Pharma Inc stock pricePortfolio Allocation Tips & Buy Sell Signal Notifications - earlytimes.in
New Strong Buy Stocks for Oct. 24: IGC, ASM and More - MSN
IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Fact - GuruFocus
IGC Pharma (IGC) Advances Alzheimer's Research with AI-Driven Ap - GuruFocus
IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Tr - PharmiWeb.com
IGC Pharma Leverages MINT-AD to Identify Socioeconomic Risk Factors Driving Alzheimer's and Aging Trends - Weatherford Democrat
IGC Pharma (NYSE: IGC) Uses MINT-AD AI to Map Socioeconomic Alzheimer’s Risks - Stock Titan
An analyst sees good growth prospects for IGC Pharma Inc (IGC) - Setenews
Will IGC Pharma Inc. stock benefit from AI adoption2025 EndofYear Setup & Intraday High Probability Alerts - newser.com
Is IGC Pharma Inc. (IGS1) stock considered safe havenEarnings Summary Report & AI Forecast Swing Trade Picks - newser.com
Is IGC Pharma Inc. (IGS1) stock undervalued after correction2025 Market Overview & Technical Pattern Based Signals - newser.com
Is IGC Pharma Inc. stock a contrarian opportunityWeekly Gains Report & Risk Controlled Swing Alerts - newser.com
IGC Pharma Inc Azioni (IGC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.36%
1.05%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):